GLYX 13 | Tocris Bioscience 3406/1 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Tocris Bioscience

product type :

chemical

product name :

GLYX 13

catalog :

3406/1

quantity :

1 mg

price :

189 USD

citations: 1

Reference
Shen M, Lv D, Liu X, Wang C. ERK/mTOR signaling may underlying the antidepressant actions of rapastinel in mice. Transl Psychiatry. 2022;12:522 pubmed publisher

product information

brand :

Tocris

master code :

3406

SKU :

3406/1

product name :

GLYX 13

unit size :

1 mg

seo description :

NMDA partial agonist; acts at the glycine site

target :

NMDA Receptor Agonists

category :

Peptides

purity :

95%

observed molecular weight :

413.47

url print :

?utm_source=biocompare&utm_medium=referral&utm_campaign=product&utm_term=peptides

details of functionality :

GLYX 13 is a NMDA receptor partial agonist that acts at the glycine site. Simultaneously acts as a promoter of the induction of long-term potentiation (LTP) and as a suppressor of long-term depression (LTD). Also promotes VGF and BDNF release and increases ERK/mTOR signaling . Exhibits nootropic, neuroprotective and antinociceptive activity, and enhances learning, memory and cognition in vivo . Brain penetrant.

top caption :

NMDA partial agonist; acts at the glycine site

extended description :

NMDA partial agonist; acts at the glycine site

formula :

C18H31N5O6

formula text :

C18H31N5O6

cas num :

117928-94-6

USD :

189 USD

product details :

NMDA partial agonist; acts at the glycine site

alt names :

Rapastinel

storage :

Store at -20░C